Steven W Taylor1, Nigel J Clarke2, Zhaohui Chen1, Michael J McPhaul1. 1. Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, United States. 2. Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, United States. Electronic address: Nigel.J.Clarke@questdiagnostics.com.
Abstract
BACKGROUND: Measurements of fasting levels of insulin and C-peptide are useful in documenting insulin resistance and may help predict development of diabetes mellitus. However, the specific insulin and C-peptide levels associated with specific degrees of insulin resistance have not been defined, owing to marked variability among immunoassays and lack of standardization. Herein, we describe a multiplexed liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for intact insulin and C-peptide. METHODS: Insulin and C-peptide were enriched from patient sera using monoclonal antibodies immobilized on magnetic beads and processed on a robotic liquid handler. Eluted peptides were analyzed by LC-MS/MS. Bovine insulin and a stable isotopically-labeled (13C/15N) C-peptide were utilized as internal standards. RESULTS: The assay had an analytical measurement range of 3 to 320 μIU/ml (18 to 1920 pmol/l) for insulin and 0.11 to 27.2 ng/ml (36 to 9006 pmol/l) for C-peptide. Intra- and inter-day assay variation was less than 11% for both peptides. Of the 5 insulin analogs commonly prescribed to treat diabetes, only the recombinant drug insulin lispro caused significant interference for the determination of endogenous insulin. There were no observed interferences for C-peptide. CONCLUSION: We developed and validated a high-throughput, quantitative, multiplexed LC-MS/MS assay for intact insulin and C-peptide.
BACKGROUND: Measurements of fasting levels of insulin and C-peptide are useful in documenting insulin resistance and may help predict development of diabetes mellitus. However, the specific insulin and C-peptide levels associated with specific degrees of insulin resistance have not been defined, owing to marked variability among immunoassays and lack of standardization. Herein, we describe a multiplexed liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for intact insulin and C-peptide. METHODS:Insulin and C-peptide were enriched from patient sera using monoclonal antibodies immobilized on magnetic beads and processed on a robotic liquid handler. Eluted peptides were analyzed by LC-MS/MS. Bovineinsulin and a stable isotopically-labeled (13C/15N) C-peptide were utilized as internal standards. RESULTS: The assay had an analytical measurement range of 3 to 320 μIU/ml (18 to 1920 pmol/l) for insulin and 0.11 to 27.2 ng/ml (36 to 9006 pmol/l) for C-peptide. Intra- and inter-day assay variation was less than 11% for both peptides. Of the 5 insulin analogs commonly prescribed to treat diabetes, only the recombinant drug insulin lispro caused significant interference for the determination of endogenous insulin. There were no observed interferences for C-peptide. CONCLUSION: We developed and validated a high-throughput, quantitative, multiplexed LC-MS/MS assay for intact insulin and C-peptide.
Authors: Debi K Swertfeger; Sandra Rebholz; Hailong Li; Amy S Shah; William Sean Davidson; Long J Lu Journal: J Clin Lipidol Date: 2018-08-27 Impact factor: 4.766
Authors: Benjamin Y Owusu; Hannah Pflaum; Russell Garner; North Foulon; Thomas J Laha; Andrew N Hoofnagle Journal: J Mass Spectrom Adv Clin Lab Date: 2020-12-28
Authors: North Foulon; Elisha Goonatilleke; Michael J MacCoss; Michelle A Emrick; Andrew N Hoofnagle Journal: J Mass Spectrom Adv Clin Lab Date: 2022-06-10
Authors: Richard G Kay; Peter Barker; Keith Burling; Mark Cohen; David Halsall; Frank Reimann; Fiona M Gribble; Robert K Semple; David Church Journal: Clin Chem Date: 2021-06-01 Impact factor: 8.327
Authors: Rain R Chen; Mingo M H Yung; Yang Xuan; Shijie Zhan; Leanne L Leung; Rachel R Liang; Thomas H Y Leung; Huijuan Yang; Dakang Xu; Rakesh Sharma; Karen K L Chan; Siew-Fei Ngu; Hextan Y S Ngan; David W Chan Journal: Commun Biol Date: 2019-07-31